Stay updated on Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, reflecting a minor adjustment to the study record metadata.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4 to reflect a new version of the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the page's content or formatting since the last version.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays an updated software revision tag, changing from v3.6.0 to v3.6.2. This reflects a platform update rather than a change to the study details or other user-facing content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now explicitly indicates that recruitment is closed and adds new help/navigation links (How to Read a Study Record, Common Questions, How to Join a Study). A formatting update replaces the Interventions heading from 'Intervention / Treatment' to 'Intervention/Treatment' and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check67 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating the latest documentation update has been applied.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Placebo in Radioiodine-Refractory Thyroid Cancer Clinical Trial page.